Common Contracts
2 similar Sales Agreement contracts by Proteostasis Therapeutics, Inc., uniQure N.V.
uniQure N.V. Up to $150,000,000 of Ordinary Shares (nominal value €0.05 per share) SALES AGREEMENTSales Agreement • March 2nd, 2020 • uniQure N.V. • Pharmaceutical preparations • New York
uniQure N.V., a Dutch public company with limited liability (naamloze vennootschap) (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC (“Leerink”), as follows:
PROTEOSTASIS THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • March 23rd, 2018 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • New York
Proteostasis Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (“Leerink”), as follows:
